Tilray Brands (TLRY) Profit After Tax (2017 - 2026)
Tilray Brands' (TLRY) quarterly Profit After Tax came in at -$49.6 million in Q2 2026, up 96.07% YoY from -$25.3 million in Q2 2025, and down 57.6% on a QoQ basis from -$31.5 million in Q1 2026.
Tilray Brands (TLRY) Profit After Tax (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Profit After Tax data on file, last reported at -$49.6 million in Q2 2026.
- Quarterly Profit After Tax rose 96.07% year-over-year to -$49.6 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$118.8 million (up 94.57% YoY) and the FY2026 annual result came in at -$122.6 million, up 94.39% from the prior year.
- Profit After Tax slipped to -$49.6 million in Q2 2026, from -$31.5 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $52.5 million in Q1 2022 to a low of -$1.3 billion in Q2 2025.
- A 5-year average of -$253.5 million and a median of -$73.4 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax soared 118.68% — and 2025, when it slumped 3878.59%.
- Tracing TLRY's Profit After Tax over 5 years: stood at -$103.9 million in 2022, then soared by 60.55% to -$41.0 million in 2023, then sank by 129.97% to -$94.2 million in 2024, then jumped by 58.57% to -$39.0 million in 2025, then declined by 27.05% to -$49.6 million in 2026.
- The last three Profit After Tax figures came in at -$49.6 million (Q2 2026), -$31.5 million (Q1 2026), and -$39.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Tilray Brands | 512.33 Mn | 277.70 Mn | 90.52 Mn | -49.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -49.61 Mn |
| Feb 28, 2026 | -31.48 Mn |
| Nov 30, 2025 | -39.05 Mn |
| Aug 31, 2025 | 1.33 Mn |
| May 31, 2025 | -1.26 Bn |
| Feb 28, 2025 | -798.92 Mn |
| Nov 30, 2024 | -94.24 Mn |
| Aug 31, 2024 | -30.49 Mn |
| May 31, 2024 | -31.75 Mn |
| Feb 29, 2024 | -109.68 Mn |
| Nov 30, 2023 | -40.98 Mn |
| Aug 31, 2023 | -52.65 Mn |
| May 31, 2023 | -142.38 Mn |
| Feb 28, 2023 | -1.20 Bn |
| Nov 30, 2022 | -103.88 Mn |
| Aug 31, 2022 | -132.45 Mn |
| May 31, 2022 | -499.92 Mn |
| Feb 28, 2022 | 52.48 Mn |
| Nov 30, 2021 | -42.88 Mn |
| Aug 31, 2021 | -136.03 Mn |